Appropriate preparation and administration of COVID-19 vaccines may depend on patient characteristics and be independent of vaccine choice, or it may depend on the specific pharmaceutical characteristics of the individual vaccine.
Our guidance and standard operating procedures cover both aspects.
In addition to our SOPs, further points of clarification related to preparation and administration are as follows.
Only vaccine batches approved under under Regulation 174 of the Human Medicine Regulations 2012 (as amended) are in the legitimate supply chain. Products supplied by AAH, Alloga or Movianto may be assumed to be approved. If there are any questions about a specific vaccine batch, please refer to your Regional QA Specialist.
It is not necessary for the same patient to receive both doses of vaccine from the same batch.
See further information if the same brand of vaccine is unavailable for the second dose